CAS No.16051-77-7,Isosorbide 5-mononitrate Suppliers

Products Categories

Pharmaceutical (143)
Organic Chemicals (26)
Others (25)
Reagent (7)
Materials (3)
Plant Extract (1)

Basic Information

Molecular Structure:
CAS No.:	16051-77-7
Name:	Isosorbide 5-mononitrate
Article Data:	26

Formula:	C₆H₉NO₆
Molecular Weight:	191.141
Synonyms:	Glucitol,1,4:3,6-dianhydro-, 5-nitrate, D- (8CI);BM 22-145;ConpinRetardkaps;Corangin SR;Duride;Elantan;ElantanLong;Elantan Retard;IS 5MN;Imdur;Imdur Durules;Imtrate;Ismo;Isomonit;Isopen 20;Isosorbidemononitrate;Iturol;Momo Mack;Monis;Monit 20;Mono-Cedocard;Mono-Mack;Monocord 20;Monoket Retard;Monolong 40;Mononit;Monopront;Monosorb;Monosordil;Monovas;Ormox;Pentacard;Vasotrate;
EINECS:	240-197-2
Density:	1.56 g/cm³
Melting Point:	88-93 °C
Boiling Point:	364.5 °C at 760 mmHg
Flash Point:	174.2 °C
Solubility:	Soluble in water
Appearance:	white to light yellow crystal powder
Hazard Symbols:	Xi,F
Risk Codes:	36/37/38-11
Safety:	37/39-16-15
Transport Information:	UN 3251
PSA:	93.74000
LogP:	-0.75500

Raw Materials

652-67-5

79-31-2

56-23-5

87-33-2

13042-39-2

7664-93-9

13042-38-1

Total:150 Page 1 of 4 1 2 3 4 Next>>

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 16051-77-7

Specification

The IUPAC name of Isosorbide 5-nitrate is [(3S,3aR,6R,6aS)-3-hydroxy-2,3,3a,5,6,6a-hexahydrofuro[3,2-b]furan-6-yl]nitrate. With the CAS registry number 16051-77-7 and EINECS 240-197-2, it is also named as 1,4:3,6-Dianhydro-D-glucitol 5-nitrate. The product's categories are Chiral; Nitric Oxide Reagents; Various Metabolites and Impurities; Heterocycles; Intermediates & Fine Chemicals; Metabolites & Impurities; Pharmaceuticals; API's. It is white to light yellow crystal powder which acts by dilating the blood vessels so as to reduce the blood pressure. When heated to decomposition it emits toxic fumes of NO_x.

The other characteristics of this product can be summarized as: (1)ACD/LogP: -0.51; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -0.51; (4)ACD/LogD (pH 7.4): -0.51; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 12.53; (8)ACD/KOC (pH 7.4): 12.53; (9)#H bond acceptors: 7; (10)#H bond donors: 1; (11)#Freely Rotating Bonds: 3; (12)Polar Surface Area: 82.74 Å²; (13)Index of Refraction: 1.542; (14)Molar Refractivity: 38.44 cm³; (15)Molar Volume: 122 cm³; (16)Polarizability: 15.24×10^-24 cm³; (17)Surface Tension: 60.2 dyne/cm; (18)Density: 1.56 g/cm³; (19)Flash Point: 174.2 °C; (20)Enthalpy of Vaporization: 70.68 kJ/mol; (21)Boiling Point: 364.5 °C at 760 mmHg; (22)Vapour Pressure: 8.66E-07 mmHg at 25°C.

Preparation of Isosorbide 5-nitrate: With sorbitol as raw materials, we can get anhydro sorbitol by dehydration cyclization. Then, after reacting with nitric acid and acetic anhydride at 10 ~ 15 °C for 2.5h, we can get the product.

Isosorbide 5-nitrate can be obtained by sorbitol

Uses of Isosorbide 5-nitrate: It is a nitrate-class drug used for the prophylactic treatment of angina pectoris. But this drug has side effects including headache and tiredness. It can react with benzoyl chloride to get benzoic acid 6-nitrooxy-hexahydro-furo[3,2-b]furan-3-yl ester. This reaction needs reagent Et₃N and solvent CHCl₃ at ambient temperature. The reaction time is 2 hours. The yield is 65%.

Isosorbide 5-nitrate can react with benzoyl chloride to get benzoic acid 6-nitrooxy-hexahydro-furo[3,2-b]furan-3-yl ester

When you are using this chemical, please be cautious about it as the following:
It is highly flammable, so people should keep it away from heat and sources of ignition. It is irritating to eyes, respiratory system and skin. If you want to contact this product, you must wear suitable gloves and eye/face protection.

People can use the following data to convert to the molecule structure.
1. SMILES:[O-][N+](=O)O[C@H]1[C@H]2OC[C@H](O)[C@H]2OC1
2. InChI:InChI=1/C6H9NO6/c8-3-1-11-6-4(13-7(9)10)2-12-5(3)6/h3-6,8H,1-2H2/t3-,4+,5+,6+/m0/s1
3. InChIKey:YWXYYJSYQOXTPL-SLPGGIOYBW

The following are the toxicity data which has been tested.

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
mouse	LD50	intraperitoneal	1810mg/kg (1810mg/kg)	BEHAVIORAL: ATAXIA SKIN AND APPENDAGES (SKIN): HAIR: OTHER	Oyo Yakuri. Pharmacometrics. Vol. 29, Pg. 327, 1985.
mouse	LD50	intravenous	1820mg/kg (1820mg/kg)	BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: ATAXIA	Oyo Yakuri. Pharmacometrics. Vol. 29, Pg. 327, 1985.
mouse	LD50	oral	1771mg/kg (1771mg/kg)		Bollettino Chimico Farmaceutico. Vol. 128, Pg. 74, 1989.
rat	LD50	intraperitoneal	1760mg/kg (1760mg/kg)	SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)	Oyo Yakuri. Pharmacometrics. Vol. 29, Pg. 327, 1985.
rat	LD50	intravenous	1750mg/kg (1750mg/kg)	BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: ATAXIA	Oyo Yakuri. Pharmacometrics. Vol. 29, Pg. 327, 1985.
rat	LD50	oral	2010mg/kg (2010mg/kg)	BEHAVIORAL: ATAXIA KIDNEY, URETER, AND BLADDER: URINE VOLUME INCREASED	Oyo Yakuri. Pharmacometrics. Vol. 29, Pg. 327, 1985.